Sarah Mundt

Sarah Mundt

Auto-generated profile, based on publicly available information

Sarah Mundt

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2019 in Science Immunology
Verified
Journal Article
Closed access
PDF file
SMSarah Mundt
Sarah Mundt
DMDunja Mrdjen
Dunja Mrdjen
SUSebastian G. Utz
Sebastian G. Utz
MGMelanie Greter
Melanie Greter
BSBettina Schreiner
Bettina Schreiner
BBBurkhard Becher
Burkhard Becher
The central nervous system (CNS) is under close surveillance by immune cells, which mediate tissue homeostasis, protection, and repair. Conversely, in neuroinflammation, dysregulated leukocyte invasion into the CNS leads to immunopathology and neurological disability. To invade the brain parenchyma, autoimmune encephalitogenic T helper (TH) cells must encounter their cognate antigens (Ags) presented via local Ag-presenting cells (APCs). The precise identity of the APC that samples, processes, and presents CNS-derived Ags to autoaggressive T cells is unknown. Here, we used a combination of high-dimensional single-cell mapping and conditional MHC class II ablation across all CNS APCs to systematically interrogate each population for its ability to reactivate encephalitogenic TH cells in vivo. We found a population of conventional dendritic cells, but not border-associated macrophages or microglia, to be essential for licensing T cells to initiate neuroinflammation.

7 January 2014 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
Michael BaslerMichael Basler
Michael Basler
SMSarah Mundt
Sarah Mundt
TMTony Muchamuel
Tony Muchamuel
CMCarlo Moll
Carlo Moll
JJJing Jiang
Jing Jiang
CKChristopher J. Kirk
Christopher J. Kirk
Multiple sclerosis (MS) is a chronic demyelinating immune mediated disease of the central nervous system. The immunoproteasome is a distinct class of proteasomes found predominantly in monocytes and lymphocytes. Recently, we demonstrated a novel function of immunoproteasomes in cytokine production and T cell differentiation. In this study, we investigated the therapeutic efficacy of an inhibitor of the immunoproteasome (ONX 0914) in two different mouse models of MS. ONX 0914 attenuated disease progression after active and passive induction of experimental autoimmune encephalomyelitis (EAE), both in MOG 35–55 and PLP 139–151 ‐induced EAE. Isolation of lymphocytes from the brain or spinal cord revealed a strong reduction of cytokine‐producing CD4 + cells in ONX 0914 treated mice. Additionally, ONX 0914 treatment prevented disease exacerbation in a relapsing‐remitting model. An analysis of draining lymph nodes after induction of EAE revealed that the differentiation to Th17 or Th1 cells was strongly impaired in ONX 0914 treated mice. These results implicate the immunoproteasome in the development of EAE and suggest that immunoproteasome inhibitors are promising drugs for the treatment of MS.

1 October 2019 in Trends in Neurosciences
Verified
Journal Article
Closed access
SMSarah Mundt
Sarah Mundt
MGMelanie Greter
Melanie Greter
AFAlexander Flügel
Alexander Flügel
BBBurkhard Becher
Burkhard Becher

12 December 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CKChristian W. Keller
Christian W. Keller
CSChristina Sina
Christina Sina
MKMonika B. Kotur
Monika B. Kotur
GRGiulia Ramelli
Giulia Ramelli
SMSarah Mundt
Sarah Mundt
JLJan Lünemann
Jan Lünemann
Significance: How autoreactive CD4 + T cells recognize their target antigen and induce sustained inflammation in organ-specific autoimmune diseases is incompletely understood. In an experimental model of multiple sclerosis, we show that accumulation of myelin-specific CD4 + T cells within the CNS and subsequent clinical disease development requires autophagy protein (ATG)-dependent phagocytosis in dendritic cells (DCs). Absence of ATG-dependent phagocytosis in DCs abrogates myelin presentation to CD4 + T cells following phagocytosis of oligodendroglial cells, and its pharmacological inhibition delays the onset and reduces the clinical severity of experimental autoimmune encephalomyelitis. Thus, DCs use ATG-dependent phagocytosis for enhanced presentation of myelin antigen during autoimmune CNS inflammation, thereby linking oligodendrocyte injury with antigen processing and autoimmune T cell pathogenicity.

2 November 2022 in Neuron
Verified
Journal Article
Closed access
SMSarah Mundt
Sarah Mundt
MGMelanie Greter
Melanie Greter
BBBurkhard Becher
Burkhard Becher

12 October 2015
Verified
Journal Article
Closed access
Michael BaslerMichael Basler
Michael Basler
SMSarah Mundt
Sarah Mundt
ABAnnegret Bitzer
Annegret Bitzer
CSChristian Schmidt
Christian Schmidt
Marcus GroettrupMarcus Groettrup
Marcus Groettrup